Recombinant RABV G (Zamerovimab Biosimilar) antibody

Catalog No. ABIN7488404

The Humanized Monoclonal anti-RABV G (Zamerovimab Biosimilar) antibody has been validated for ELISA and WB. It is suitable to detect RABV G (Zamerovimab Biosimilar) in samples from Lyssavirus rabies (RABV).

Quick Overview for Recombinant RABV G (Zamerovimab Biosimilar) antibody (ABIN7488404)

Target: RABV G (Zamerovimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Lyssavirus rabies (RABV)

Host: Humanized

Clonality: Monoclonal

Conjugate: This RABV G (Zamerovimab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-RABV G (Zamerovimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Zamerovimab Biosimilar - Anti-G Glycoprotein mAb - Research Grade

Characteristics: IgG1, kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1, kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: 0.01M PBS, pH 7.4.

Handling Advice: Avoid repeated freeze-thaw cycles

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year), Avoid repeated freeze-thaw cycles

Expiry Date: 12 months

Target Details for RABV G (Zamerovimab Biosimilar)

Target: RABV G (Zamerovimab Biosimilar)

Alternative Name: Zamerovimab Biosimilar

Target Type: Biosimilar

Background: Anti-G, Anti-Glycoprotein, CTB 011, CTB-011, CTB011, SYN023

UniProt: O92284, P08667

CAS-No: CAS: 2419087-87-7